RESPIRATORY TRACT DISEASES

This study is checking how well the ABRYSVO RSV vaccine works when given to pregnant people to protect their babies after birth. Researchers are looking at hospital records from Argentina and Uruguay to see if vaccinated mothers had infants with fewer severe RSV infections. The g…

This study aims to see how well a vaccine (ABRYSVO) given to pregnant women works in the real world to protect their babies from being hospitalized with severe RSV lung infections. Researchers will look at the medical records of babies under 1 year old who were hospitalized in Au…

This program provides access to the experimental drug taletrectinib for adults with advanced ROS1-positive lung cancer who have run out of approved treatment options and cannot join regular clinical trials. The drug aims to control cancer growth in patients who have already tried…

This study is testing if a drug called bevacizumab can help adults with recurrent respiratory papillomatosis (RRP), a rare condition causing wart-like growths in the airways. Participants, who currently need surgery multiple times a year to clear these growths, will receive bevac…

This study is observing how well a combination of the drug Osimertinib and standard chemotherapy works for people with a specific type of advanced lung cancer (EGFR-positive NSCLC) in a real-world setting. It involves 532 adult patients who have already started this specific trea…

This study is testing a new medical device called the Aventus Thrombectomy System. It is designed to physically remove dangerous blood clots from the lungs of patients with a sudden, severe pulmonary embolism. The trial will enroll 130 adults to see if the procedure is safe and e…

This study aims to see if providing standardized training to cancer doctors in smaller city and county hospitals leads to better testing and treatment for patients with advanced non-small cell lung cancer. It will follow 1,000 patients to measure if doctors order more recommended…